Cost-effectiveness of statin therapy for secondary prevention among patients with coronary artery disease and baseline LDL-C 70-100  mg/dL in Taiwan.

CONCLUSION: Lowering the target LDL-C level from 100 to 70 mg/dL among treatment-naïve CAD patients could be cost-effective given the health benefits of preventing cardiovascular events and deaths.
PMID: 32081563 [PubMed - as supplied by publisher]

Source: J Formos Med Assoc - February 17, 2020 Category: General Medicine Authors: Lin FJ, Shyu KG, Hsieh IC, Huey-Herng Sheu W, Tu ST, Yeh SJ, Chen CI, Lu KC, Wu CC, Shau WY, Inocencio TJ, Wen YC, Yeh HI Tags: J Formos Med Assoc Source Type: research